MedTrace Logo

Adding MgSO4 to Epidural Levobupivacaine in CS for Patients With Preeclampsia

NCT02699827 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2017-06-06

No results posted yet for this study

Summary

This study aims at evaluating the effect of adding magnesium sulphate epidurally as an adjunct to levobupivacaine on the quality of anesthesia and perioperative pain relief in patients with preeclampsia undergoing elective caesarian section (CS).

Conditions

Interventions

DRUG

Levobupivacaine hydrochloride

Patients will receive epidural 20 ml levobupivacaine hydrochloride 0.5%

DRUG

Magnesium sulphate

Patients will receive epidural 5 ml magnesium sulphate 10%

DRUG

Saline 0.9%

Patients will receive epidural 5 ml saline 0.9%

Sponsors & Collaborators

  • Mohamed Sayed Abdelhafez

    lead OTHER

Principal Investigators

  • Tamer Elmetwally, Dr · Mansoura University

  • Mohamed S Abdelhafez, Dr · Mansoura University

  • Reem A Elsharkawy, Dr · Mansoura University

  • Waleed El-refaie, Dr · Mansoura University

  • Alaa Wageeh, Dr · Mansoura University

  • Salwa S Hays, Prof · Mansoura University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2017-01-31
Completion
2017-01-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02699827 on ClinicalTrials.gov